FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula (I)
, pharmaceutical compositions based on the said compounds, as well as methods of using said compounds in preparing medicinal agents.
EFFECT: obtaining compounds and a composition which can inhibit phosphatase cdc25, particularly phosphatase cdc25-C and can be particularly used for treating cancer.
12 cl, 56 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF BENZOTIAZOLE-4,7-DION AND BENZOXAZOLE-4,7-DION, PRODUCTION AND THERAPEUTIC APPLICATION | 2002 |
|
RU2326664C2 |
| ARYLMETHOXY ISOINDOLIN DERIVATIVE, COMPOSITIONS INCLUDING THEREOF AND METHODS OF THEIR APPLICATION | 2011 |
|
RU2567753C2 |
| 1-SULFONYL-1,3-DIHYDROINDOLE-2-ONES, PHARMACEUTICAL COMPOSITIONS (VARIANTS), METHOD FOR THEIR PREPARING AND APPLYING | 2003 |
|
RU2259999C2 |
| NOCICEPTIN ANALOGUES | 2002 |
|
RU2426730C2 |
| TRICYCLIC COMPOUND AND JAK INHIBITOR | 2015 |
|
RU2674262C2 |
| DERIVATIVES OF BENZIMIDAZOLIDINONE AS AGENTS FOR MUSCARINIC RECEPTORS | 2002 |
|
RU2288919C2 |
| IMIDAZOLIDINE-2,4-DIONE DERIVATIVES, POSSESSING ANTIPROLIFERATIVE ACTIVITY | 2010 |
|
RU2555999C2 |
| METHODS FOR TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH USE OF 2,4-PYRIMIDINEDIAMINE | 2013 |
|
RU2659777C2 |
| NOVEL COMPOUNDS | 2005 |
|
RU2395511C2 |
| MACROHETEROCYCLIC NUCLEOSIDE DERIVATIVES AND ANALOGUES THEREOF, PRODUCTION AND USE | 2017 |
|
RU2731385C1 |
